Assmann, Susan F.

Spironolactone for heart failure with preserved ejection fraction

Pitt, B., Pfeffer, M. A., Assmann, S. F., Boineau, R., Anand, I. S., Claggett, B., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., et al. (2014) · New England Journal of Medicine

Heart Failure Treatment and ManagementHormonal Regulation and Hypertension

Cited by 2,809

Subgroup analysis and other (mis)uses of baseline data in clinical trials

Assmann, S. F., Pocock, S. J., Enos, L. E., & Kasten, L. E. (2000) · The Lancet

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 1,167

Confidence intervals for measures of interaction

Assmann, S. F., Hosmer, D. W., Lemeshow, S., & Mundt, K. A. (1996) · Epidemiology

Colorectal Cancer Screening and DetectionGenetic factors in colorectal cancer

Cited by 262

Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection

Price, T. H., Boeckh, M., Harrison, R. W., McCullough, J., Ness, P. M., Strauss, R. G., Nichols, W. G., Hamza, T. H., Cushing, M. M., King, K. E., et al. (2015) · Blood

Neutropenia and Cancer InfectionsBlood disorders and treatments

Cited by 254

Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial

Lewis, E. F., Kim, H.-Y., Claggett, B., Spertus, J., Heitner, J. F., Assmann, S. F., Kenwood, C. T., Solomon, S. D., Desai, A. S., Fang, J. C., et al. (2016) · Circulation: Heart Failure

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 114

Early Developmental Changes in the Chemoarchitecture of the Human Inferior Olive: A Review

Armstrong, D. D., Assmann, S., & Kinney, H. C. (1999) · Journal of Neuropathology and Experimental Neurology

Neurogenesis and neuroplasticity mechanismsNeuroscience and Neuropharmacology Research

Cited by 24